Cargando…

Corrigendum to: Exposure‐safety analysis of QTc interval and transaminase levels following bedaquiline administration in patients with drug‐resistant tuberculosis

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431036/ https://www.ncbi.nlm.nih.gov/pubmed/37357371 http://dx.doi.org/10.1002/psp4.13005

Ejemplares similares

Exposure–safety analysis of QTc interval and transaminase levels following bedaquiline administration in patients with drug‐resistant tuberculosis
por: Tanneau, Lénaïg, et al.
Publicado: (2021)

Bedaquiline for multidrug-resistant tuberculosis and QTc prolongation in California
por: Katrak, Shereen, et al.
Publicado: (2021)

Diversity and evolution of drug resistance mechanisms in Mycobacterium tuberculosis [Corrigendum]
Publicado: (2017)

Rapid Molecular Assays for the Diagnosis of Drug-Resistant Tuberculosis [Corrigendum]
Publicado: (2022)

Delamanid expanded access novel treatment of drug resistant tuberculosis [Corrigendum]
Publicado: (2016)

Corrigendum to “Safety of integrated mass drug administration of azithromycin, albendazole and ivermectin versus standard treatment regimens: a cluster-randomised trial in Ethiopia”
por: McPherson, Scott, et al.
Publicado: (2023)

Raw milk producers with high levels of hygiene and safety – CORRIGENDUM
por: Berge, A. C., et al.
Publicado: (2020)

Corrigendum to “Large Gliadin Peptides Detected in the Pancreas of NOD and Healthy Mice following Oral Administration”
por: Bruun, Susanne W., et al.
Publicado: (2017)

Corrigendum to “Sugammadex-Enhanced Neuronal Apoptosis following Neonatal Sevoflurane Exposure in Mice”
por: Satomoto, Maiko, et al.
Publicado: (2017)

Efficacy and safety of QVA149 compared to the concurrent administration of its monocomponents indacaterol and glycopyrronium: the BEACON study [Corrigendum]
Publicado: (2014)

Corrigendum to “Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs” [Clin. Mass Spectrom. 14(Part A) (2019) 34–45]
por: Kuhlin, Johanna, et al.
Publicado: (2022)

Clinical experimentation with aerosol antibiotics: current and future methods of administration [Corrigendum]
Publicado: (2014)

Problems with Bazett QTc correction in paediatric screening of prolonged QTc interval
por: Andršová, Irena, et al.
Publicado: (2020)

Bedaquiline exposure in pregnancy and breastfeeding in women with rifampicin‐resistant tuberculosis
por: Court, Richard, et al.
Publicado: (2022)

Psychotropic Drugs and Prolonged QTc Interval: Does it Really that Matter?
por: Naguy, Ahmed
Publicado: (2016)

Time of the Day and Magnitude of the Effect of a Drug on the QTc Interval
por: Täubel, J, et al.
Publicado: (2017)

Impact of the Time Interval Between Primary Debulking Surgery and Start of Adjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer [Corrigendum]
Publicado: (2021)

Ketamine-induced QTc interval prolongation
por: Singh, Tejinder S. Swaran, et al.
Publicado: (2017)

Ticagrelor-Induced Prolongation of the QTc Interval
por: Ray, Avik, et al.
Publicado: (2019)

The corrected QT (QTc) prolongation in hyperthyroidism and the association of thyroid hormone with the QTc interval
por: Lee, Ye Seung, et al.
Publicado: (2015)

Corrigendum to “Drug Delivery Nanoparticles in Skin Cancers”
por: Dianzani, Chiara, et al.
Publicado: (2021)

Corrigendum: A first step toward understanding patient safety
por: Kim, Kyoung Ok
Publicado: (2017)

Multiple drugs: QTc interval prolongation following off-label use: 5 case reports
Publicado: (2022)

Corrigendum to Serum hepcidin levels in multiple sclerosis
Publicado: (2020)

Bedaquiline: A novel drug to combat multiple drug-resistant tuberculosis
por: Goel, Divya
Publicado: (2014)

Corrigendum for Evidence supporting a role for circulating macrophages in the regression of vascular remodeling following sub-chronic exposure to hemoglobin plus hypoxia
Publicado: (2021)

Progression of breast cancer following locoregional ipsilateral recurrence: importance of interval time
por: Melvin, Jennifer C, et al.
Publicado: (2016)

Corrigendum to: Repeated but not Single Administration of Ketamine Prolongs Increases of the Firing Activity of Norepinephrine and Dopamine Neurons
por: Iro, Chidiebere M, et al.
Publicado: (2021)

Continuous Intravenous versus Subcutaneous Administration of Insulin for Glycemic Variability in Acute Ischemic Stroke [Corrigendum]
Publicado: (2022)

New drugs to treat multidrug-resistant tuberculosis: the case for bedaquiline
por: Leibert, Eric, et al.
Publicado: (2014)

Bedaquiline: First FDA-approved tuberculosis drug in 40 years
por: Mahajan, Rajiv
Publicado: (2013)

Bedaquiline and Linezolid for Extensively Drug-Resistant Tuberculosis in Pregnant Woman
por: Jaspard, Marie, et al.
Publicado: (2017)

Adverse effects of bedaquiline in patients with extensively drug-resistant tuberculosis
por: Gaida, Razia, et al.
Publicado: (2020)

Drug prescription appropriateness in the elderly: an Italian study [Corrigendum]
Publicado: (2017)

Response to “Time of the Day and Magnitude of the Effect of a Drug on the QTc Interval”
por: Kervezee, L, et al.
Publicado: (2017)

Considerations for drug interactions on QTc interval in exploratory COVID-19 treatment
por: Roden, Dan M., et al.
Publicado: (2020)

Considerations for Drug Interactions on QTc Interval in Exploratory COVID-19 Treatment
por: Roden, Dan M., et al.
Publicado: (2020)

Chloroquine for treatment of COVID-19 results in subtherapeutic exposure and prolonged QTc intervals
por: Brüggemann, R.J., et al.
Publicado: (2021)

Corrigendum to “Safety and Clinical Usage of Newcastle Disease Virus in Cancer Therapy”
por: Lam, Han Yuen, et al.
Publicado: (2017)

A Clinical Investigation of the Performance and Safety of Epaderm®, an Emollient Cream [Corrigendum]
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qm38isgssm9m8r2jka2jgntjv7